Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines - PubMed (original) (raw)
Review
. 2008 Oct 21;179(9):920-6.
doi: 10.1503/cmaj.080554. Epub 2008 Sep 18.
Affiliations
- PMID: 18801878
- PMCID: PMC2565732
- DOI: 10.1503/cmaj.080554
Review
Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines
Onil K Bhattacharyya et al. CMAJ. 2008.
No abstract available
Figures
Similar articles
- Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ; American Heart Association; American Diabetes Association. Buse JB, et al. Circulation. 2007 Jan 2;115(1):114-26. doi: 10.1161/CIRCULATIONAHA.106.179294. Epub 2006 Dec 27. Circulation. 2007. PMID: 17192512 - Cardio-diabetology: The new 'sweetheart' in cardiovascular prevention.
Aboyans V, Cosentino F. Aboyans V, et al. Eur J Prev Cardiol. 2019 Dec;26(2_suppl):5-6. doi: 10.1177/2047487319887483. Eur J Prev Cardiol. 2019. PMID: 31766919 No abstract available. - Diabetes mellitus Canadian clinical practice guidelines update.
Ledger S. Ledger S. CANNT J. 2004 Jul-Sep;14(3):38-44; quiz 44-5. CANNT J. 2004. PMID: 15537040 Review. - Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.
Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Langkilde AM, Plutzky J, Rydén L, Scheen A, Standl E, Tuomilehto J, Zannad F. Cosentino F, et al. Eur Heart J. 2019 Sep 7;40(34):2907-2919. doi: 10.1093/eurheartj/ehy677. Eur Heart J. 2019. PMID: 30445605 No abstract available. - Diabetes, prediabetes and cardiovascular risk.
Mellbin LG, Anselmino M, Rydén L. Mellbin LG, et al. Eur J Cardiovasc Prev Rehabil. 2010 May;17 Suppl 1:S9-14. doi: 10.1097/01.hjr.0000368192.24732.2f. Eur J Cardiovasc Prev Rehabil. 2010. PMID: 20489420 Review.
Cited by
- Early detection of type 2 diabetes risk: limitations of current diagnostic criteria.
Zhang J, Zhang Z, Zhang K, Ge X, Sun R, Zhai X. Zhang J, et al. Front Endocrinol (Lausanne). 2023 Nov 9;14:1260623. doi: 10.3389/fendo.2023.1260623. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38027114 Free PMC article. - A bibliometric analysis of RNA methylation in diabetes mellitus and its complications from 2002 to 2022.
Zhang W, Zhang S, Dong C, Guo S, Jia W, Jiang Y, Wang C, Zhou M, Gong Y. Zhang W, et al. Front Endocrinol (Lausanne). 2022 Sep 8;13:997034. doi: 10.3389/fendo.2022.997034. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36157472 Free PMC article. Review. - Roles of Cardiometabolic Factors in Mediating the Causal Effect of Type 2 Diabetes on Cardiovascular Diseases: A Two-Step, Two-Sample Multivariable Mendelian Randomization Study.
Chen K, Zhuang Z, Shao C, Zheng J, Zhou Q, Dong E, Huang T, Tang YD. Chen K, et al. Front Cardiovasc Med. 2022 Feb 24;9:813208. doi: 10.3389/fcvm.2022.813208. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35282373 Free PMC article. - Establishment of Clinical Prediction Model Based on the Study of Risk Factors of Stroke in Patients With Type 2 Diabetes Mellitus.
Shi R, Zhang T, Sun H, Hu F. Shi R, et al. Front Endocrinol (Lausanne). 2020 Aug 25;11:559. doi: 10.3389/fendo.2020.00559. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32982965 Free PMC article. - Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.
Chia CW, Egan JM, Ferrucci L. Chia CW, et al. Circ Res. 2018 Sep 14;123(7):886-904. doi: 10.1161/CIRCRESAHA.118.312806. Circ Res. 2018. PMID: 30355075 Free PMC article. Review.
References
- Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(suppl 1):S1-201. Available: www.diabetes.ca/for-professionals/resources/2008-cpg/. - PubMed
- Booth GL, Kapral MK, Fung K, et al. Recent trends in cardiovascular complications among men and women with and without diabetes. Diabetes Care 2006;29:32-7. - PubMed
- National Institute for Clinical Excellence. The guideline development process: an overview for stakeholders, public and the NHS (3rd ed). London (UK): The Institute; 2007. Available: www.nice.org.uk/media/830/B9/GuidelinesManualDevelopmentProcess.pdf (accessed 2008 Sep 6).
- Australian Centre for Diabetes Strategies. Introduction and overview of the guideline development process. In: National evidence based guidelines for the management of type 2 diabetes mellitus. Sydney (Australia): National Health and Medical Research Council; 2005. Available: www.nhmrc.gov.au/publications/synopses/_files/di7.pdf (accessed 2008 Sep 6).
- Jackson R, Lawes CM, Bennett DA, et al. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet 2005;365:434-41. - PubMed